Rubius Therapeutics Inc (RUBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RUBY | BMY | AMGN | GILD | VRTX |
| Company | Rubius Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.2475 | 72.94 | 249.16 | 84.01 | 321.50 |
| High | 0.2725 | 72.94 | 249.55 | 84.24 | 323.10 |
| Low | 0.2475 | 70.81 | 240.00 | 82.70 | 312.58 |
| Last | 0.2700 | 71.21 | 245.43 | 84.39 | 316.35 |
| Change | +0.0100 | -1.44 | -6.97 | +0.45 | -6.75 |
| % Change | +3.85% | -1.98% | -2.76% | +0.54% | -2.09% |
| Volume | 301,661 | 6,641,175 | 3,549,060 | 2,921,647 | 658,627 |
| 20-Day Average Volume | 1,509,919 | 8,153,717 | 2,212,833 | 6,130,258 | 1,436,293 |
| Previous Close | 0.2605 | 72.65 | 252.40 | 83.94 | 323.10 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2418 | 72.44 | 262.97 | 84.83 | 305.41 |
| 20-Day Raw Stochastic | 73.55% | 12.94% | 12.62% | 30.10% | 78.57% |
| 20-Day Relative Strength | 54.44% | 41.47% | 29.84% | 49.04% | 57.14% |
| Weighted Alpha | -89.05 | +3.90 | +4.60 | +37.60 | +29.30 |
| Today's Opinion | 40% Sell | 56% Sell | 8% Sell | 40% Buy | 88% Buy |
| Previous Opinion | 40% Sell | 40% Sell | 8% Sell | 40% Buy | 88% Buy |
| Last Month's Opinion | 80% Sell | 24% Sell | 40% Buy | 80% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.30% since 01/25/23 | -2.56% since 01/25/23 | -4.63% since 01/25/23 | -0.12% since 01/25/23 | +0.22% since 01/25/23 |
| Low | 0.2400 on 01/31/23 | 70.81 on 02/01/23 | 240.00 on 02/01/23 | 82.33 on 01/30/23 | 312.63 on 02/01/23 |
| High | 0.2850 on 01/27/23 | 73.45 on 01/27/23 | 256.69 on 01/26/23 | 84.21 on 01/31/23 | 325.19 on 01/31/23 |
| 1-Month | |||||
| %Chg | +53.09% since 12/30/22 | -0.90% since 12/30/22 | -6.85% since 12/30/22 | -2.19% since 12/30/22 | +9.42% since 12/30/22 |
| Low | 0.1500 on 01/06/23 | 70.75 on 01/09/23 | 240.00 on 02/01/23 | 82.11 on 01/24/23 | 282.21 on 01/09/23 |
| High | 0.3103 on 01/13/23 | 75.00 on 01/24/23 | 276.84 on 01/11/23 | 88.29 on 01/06/23 | 325.19 on 01/31/23 |
| 3-Month | |||||
| %Chg | -23.91% since 11/01/22 | -8.24% since 11/01/22 | -10.07% since 11/01/22 | +5.84% since 11/01/22 | +0.57% since 11/01/22 |
| Low | 0.1400 on 12/28/22 | 70.75 on 01/09/23 | 240.00 on 02/01/23 | 77.16 on 11/03/22 | 282.21 on 01/09/23 |
| High | 0.4200 on 12/28/22 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 325.19 on 01/31/23 |
| 6-Month | |||||
| %Chg | -58.91% since 08/01/22 | -3.15% since 08/01/22 | -0.40% since 08/01/22 | +40.89% since 08/01/22 | +15.39% since 08/01/22 |
| Low | 0.1400 on 12/28/22 | 65.95 on 08/30/22 | 223.30 on 09/22/22 | 59.29 on 08/02/22 | 271.61 on 08/03/22 |
| High | 1.4600 on 09/08/22 | 81.43 on 12/01/22 | 296.67 on 11/08/22 | 89.74 on 12/13/22 | 325.19 on 01/31/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 23,542 | 154,465,520 | 134,675,328 | 105,281,248 | 82,936,864 |
| Shares Outstanding, K | 90,372 | 2,126,160 | 533,579 | 1,254,244 | 256,691 |
| Annual Sales | 0 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 7,574,400,000 |
| Annual Net Income | -196,550,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 2,342,100,000 |
| Last Quarter Sales | 0 | 11,218,000,000 | 6,652,000,000 | 7,042,000,000 | 2,334,300,000 |
| Last Quarter Net Income | -62,873,000 | 1,606,000,000 | 2,143,000,000 | 1,789,000,000 | 930,500,000 |
| 60-Month Beta | 2.32 | 0.44 | 0.67 | 0.45 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/09/22 | 1.99 on 10/25/22 | 4.09 on 01/31/23 | 1.90 on 10/27/22 | 4.01 on 10/27/22 |
| Latest Earnings Date | 02/24/23 | 02/02/23 | 01/31/23 | 02/02/23 | 02/07/23 |
| Most Recent Dividend | N/A | 0.570 on 01/05/23 | 1.940 on 11/16/22 | 0.730 on 12/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 01/05/23 | 02/14/23 | 12/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.34 | 14.01 | 13.25 | 24.22 |
